Potent anti‐inflammatory effect of a novel furan‐2,5‐dione derivative, BPD, mediated by dual suppression of COX‐2 activity and LPS‐induced inflammatory gene expression via NF‐κB inactivation
Open Access
- 13 September 2011
- journal article
- Published by Wiley in British Journal of Pharmacology
- Vol. 165 (6) , 1926-1940
Abstract
BACKGROUND AND PURPOSE We previously reported that 3‐(benzo[d]‐1,3‐dioxol‐5‐yl)‐4‐phenylfuran‐2,5‐dione (BPD) showed strong inhibitory effects on PGE2 production. However, the exact mechanism for the anti‐inflammatory effect of BPD is not completely understood. In this study, we investigated the molecular mechanism involved in the effects of BPD on inflammatory mediators in LPS‐stimulated macrophages and animal models of inflammation.EXPERIMENTAL APPROACH The expressions of COX‐2, inducible NOS (iNOS), TNF‐α, IL‐6 and IL‐1β, in LPS‐stimulated RAW 264.7 cells and murine peritoneal macrophages, were determined by Western blot and/or qRT‐PCR, respectively. NF‐κB activation was investigated by EMSA, reporter gene assay and Western blotting. Anti‐inflammatory effects of BPD were evaluated in vivo in carrageenan‐induced paw oedema in rats and LPS‐induced septic shock in mice.KEY RESULTS BPD not only inhibited COX‐2 activity but also reduced the expression of COX‐2. In addition, BPD inhibited the expression of iNOS, TNF‐α, IL‐6 and IL‐1β at the transcriptional level. BPD attenuated LPS‐induced DNA‐binding activity and the transcription activity of NF‐κB; this was associated with a decrease in the phosphorylation level of inhibitory κB‐α (IκB‐α) and reduced nuclear translocation of NF‐κB. Furthermore, BPD suppressed the formation of TGF‐β‐activated kinase‐1 (TAK1)/TAK‐binding protein1 (TAB1), which was accompanied by a parallel reduction of phosphorylation of TAK1 and IκB kinase (IKK). Pretreatment with BPD inhibited carrageenan‐induced paw oedema and LPS‐induced septic death.CONCLUSION AND IMPLICATIONS Taken together, our data indicate that BPD is involved in the dual inhibition of COX‐2 activity and TAK1‐NF‐κB pathway, providing a molecular basis for the anti‐inflammatory properties of BPD.Keywords
This publication has 39 references indexed in Scilit:
- TLR-signaling NetworksJournal of Dental Research, 2010
- Synthesis and PGE2 production inhibition of 1H-furan-2,5-dione and 1H-pyrrole-2,5-dione derivativesBioorganic & Medicinal Chemistry Letters, 2010
- TAB4 Stimulates TAK1-TAB1 Phosphorylation and Binds Polyubiquitin to Direct Signaling to NF-κBJournal of Biological Chemistry, 2008
- Toll-like Receptor 4 Mediates Induction of the Bcl10-NFκB-Interleukin-8 Inflammatory Pathway by Carrageenan in Human Intestinal Epithelial CellsJournal of Biological Chemistry, 2008
- Statin (Cerivastatin) Protects Mice Against Sepsis-Related Death via Reduced Proinflammatory Cytokines and Enhanced Bacterial ClearanceSurgical Infections, 2008
- Cyclooxygenase-2 (COX-2) in Carcinogenesis and Selective COX-2 Inhibitors for Chemoprevention in Gastrointestinal CancersJournal of Gastrointestinal Cancer, 2007
- Ubiquitin-mediated activation of TAK1 and IKKOncogene, 2007
- Mammalian MAP kinase signalling cascadesNature, 2001
- LPS induction of gene expression in human monocytesCellular Signalling, 2001
- Phosphorylation‐dependent activation of TAK1 mitogen‐activated protein kinase kinase kinase by TAB1FEBS Letters, 2000